Fungal Pathogens in Humans Essay

Fungal Pathogens in Humans Essay

Though there are well over seventy thousand true fungal species that inhabit this planet, very few of these cause diseases in humans, called mycoses. Many more fungal diseases are associated with various plants and other animals.

Mycoses in humans can range from superficial infections to deep-seated systemic infections that are life threatening. The superficial mycoses follow a similar pattern to most bacterial and viral diseases: incubation period is relatively short, onset of disease is sudden and symptoms decrease in severity over time, often with spontaneous healing.Deep-seated mycoses, however, show similarities to aberrant bacterial diseases such as leprosy and tuberculosis: incubation is short, onset of symptoms is varied, and symptoms increase in severity, often resulting in death (Ainsworth 1952). Fungal Pathogens in Humans Essay.  The types of mycoses can be broken into three major groups: cutaneous infections (affecting the outer layers of skin), subcutaneous infections (affecting the tissue below the skin) and systemic (affecting multiple organs in the body). These infections differ from one another in severity of symptoms and mode of transmission, and cause a wide variety of diseases in humans.

This paper does not attempt to cover all human mycoses, but rather those that are interesting from a mycologist’s perspective. Cutaneous Infections Cutaneous fungal infections are those that involve the outer layers of the skin and cause an inflammatory or allergic response. Most cutaneous infections are caused by specialized fungi that thrive on keratinised tissues such as skin, hair, and nails (Kendrick 2000). These organisms are a taxonomically related group of fungi called the dermatophytes. There are approximately forty species of dermatophytes grouped into three genera: Epidermophyton, Microsporum and Trichophyton.Those with sexual stages have teleomorphs in Nannizzia or Arthroderma (Cole and Hoch 1991).

ORDER A PLAGIARISM-FREE PAPER NOW

In a saprophytic environment, dermatophytes will produce either large multiseptate macroconidia or unicellular globular microconidia, depending on the organism (Ainsworth 1952). Once the fungus is established as a parasite, it produces only arthroconidia, which are thick walled and may be covered in spine-like projections.This type of spore is spread from person to person on dead skin and fallen hairs (Cole and Hoch 1991). There must be some evolutionary advantage to producing arthroconidia that accompanied the dermatophyte’s progression from geophillic to zoophillic or anthropophillic. The initial association with animals probably occurred in soil-inhabiting rodents. The saprophytic conidia of the soil dermatophytes are quite numerous, and would have been the mode of transfer to the rodents.Dermatophytes are also classified on the basis of the environment in which they are often found. Geophillic strains are able to grow and strive in soil, surviving with a saprophytic mechanism, but these can also be isolated from the hair of some animals. Zoophillic dermatophytes such as Microsporum canis, found on cats, usually parasitize animals other than humans, but some have been found in human infections as well (Campbell and Stewart 1980).Anthropophillic strains are primarily parasitic on humans, and account for slightly less than half of the known dermatophytes (Cole and Hoch 1991). The mechanism of transmission of the fungus is dependent on three different types of spores. Fungal Pathogens in Humans Essay.

Once the transition to a parasitic mode of life was established, the fungus could afford to produce the less abundant arthroconidia.Now it could depend on the common rodent-to-rodent contact for spore dispersal instead of producing several propagules in hopes that one may attach to a patch of fur. One of the most prevalent dermatophytoses is tinea capitis, or ringworm of the scalp. Deriving its name from its similarity in appearance to the marks in cloth made by the moth Tineola biselliella, tinea was first recorded in 1686 in the Philippines (Ainsworth 1952). It is often found in young children, as they are known to be missing several fatty acids that are known fungicides and often play close to one another, allowing for infection to spread rather easily.Poor nutrition, inadequate hygiene, and living with infected pets are also factors increasing the spread of ringworm (Wisuthsarewong et al.

1996). The disease is identified by hairs broken off a few millimetres above the scalp, progressing in a ring-like fashion as the fungal hyphae grow out to attain more resources (Ainsworth 1952). Tinea capitis is normally caused by Trichophyton tonsurans or Microsporum audouinii, which often stimulate epithelial cells to divide more often than usual, increasing the amount of keratin available to the fungus (Kendrick 2000). There are three identified forms of infection in Tinea capitis.Endothrix infection begins by penetration of the hair, then the hyphae grow up the interior main axis of the hair, where hyphal segments fragment into arthroconidia.

Growth near the root can also produce a fringe of delicate hyphae surrounding the root called Adamson’s Fringe (Campbell and Stewart 1980). In favus infection, there is endothrix-style growth, but arthroconidia do not form. Finally, ectothrix infection begins as in endothrix, but the hyphae extend back out through the hair cuticle and form a mass of arthroconidia both within and around the hair shaft (Patterson and McGinnis 2003).Due to these obvious morphological differences in dermatophytes, microscopic examination can aid in the identification of the fungal species involved.

Another method of identifying a case of dermatophytosis is the Wood’s Lamp test, used quite frequently by public health officials . In this test, an ultraviolet lamp is shone over a suspected area of Tinea capitis infection. If hairs glow a bright green colour, it is a sign of infection, since the fungal by-products tend to fluoresce (Wisuthsarewong et al. 1996).

This is not a completely reliable identification method, however, since some dermatophytes do not glow.Following a procedure called hair baiting, detailed by John Rippon from the Pritzler School of medicine, I attempted to isolate Trichophyton tonsurans from soil. According to Rippon (1974), placing human hair on soil from a nutrient-rich area (such as a flower bed) can produce a vast number of keratinophillic fungi. Fungal Pathogens in Humans Essay. After two weeks of incubation, I examined the hair under an ultraviolet light, finding a few small patches of bright green fluorescence. Examination under a microscope did not show any noticeable hyphal growth, but without proper dyes, an endothrix infection may have been undetected.Dermatophytoses are also found on other parts of the body.

Tinea pedis (athlete’s foot) and tinea cruris (jock itch) are often caused by Epidermophyton fluccosum (Kendrick 2000). Chronic ringworm of the body (Tinea imbricata) is found in Polynesians, caused by Trichophyton concentricum. Despite the various forms of dermatophytoses, the clinical manifestations are all due to irritants they produce, such as proteases, peptidases, and elastases, making the condition a form of toxic dermatitis (Kendrick 2000). Subcutaneous InfectionsSubcutaneous mycoses include a variety of infections characterized by the development of a large lesion at the point where the fungus enters the body, with little spreading from this site (Rippon 1974). Unlike many other modes of infection, whose primary mode of entry is through the inhalation of spores, subcutaneous infections result from traumatic implantation of the fungus into the skin (Cole and Hoch 1991).

Since the fungi that cause these infections are saprobic, generally living on soil, this implantation occurs when spores or fungal tissues enter the skin through a cut or a prick from a thorn (Kendrick 2000).Once in the body, the fungus adapts to its environment, often changing its morphology from a mycelial form to several single-celled yeasts, a condition called dimorphism (Kendrick 2000). Not all species that cause subcutaneous mycoses show the same degree of virulence and not all change their morphology, making this a quite diverse group. The degree and type of dimorphism exhibited by these organisms depends both on the individual species as well as the condition of the host’s immune system. Some species adapt to their environment quite easily and form rapidly dividing yeasts that can spread infection quite easily.

In a host with an immune deficiency, however, the same fungus may remain mycelial in morphology since there is no need to produce an army of yeast to defend against the immune system (Rippon 1974). There is relatively little literature pertaining to subcutaneous mycoses since they occur mostly in tropic environments, and very seldom appear in North America (Campbell and Stewart 1980). Eumycetoma is a subcutaneous fungal infection caused by Madurella mycetomatis, endemic almost exclusively in Sudan (Ahmed et al. 2002).After the initial implantation of the fungus, Madurella remains inactive until another stress such as a cut or thorn prick occurs.

After this time, a large lesion forms on the skin at the point of injury, under which a large swelling tumour develops. It often ruptures and the hyphae (rarely yeast in this case) burrow back down into the damaged tissue (Rippon 1994). Though very debilitating, Eumycetoma does not spread to internal organs and rarely causes death (Ahmed et al. 2002). Chromomycosis is another subcutaneous infection isolated from the soil rich with decaying vegetation and rotting wood.The disease is usually caused by the fungus Phialophora verrucosa, but there are many other fungal species involved.

The name of the disease is taken from the richly pigmented mycelia, spores, and sclerotic cells of the causative fungi. The clinical manifestation of the disease is similar to Eumycetomas, with lesions appearing at the site of fungal penetration (Sugar and Lyman, 1997). Instead of forming tumours, however, Chromomycosis produces raised lesions with a scaly, dull, and red to greyish surface, which may become secondarily infected by other bacteria (Rippon 1974).Again, there have been no deaths associated with this infection, as it is not likely to spread to other regions of the body. Systemic Infections Systemic infections result from inhalation of spores produced by the fungi that often live in soil or rotting vegetation.

Unlike subcutaneous diseases, these infections have the ability to spread to several organs in the body. The systemic infection Histoplasmosis is caused by the ascomycete Histoplasma Capsulatum. It is endemic in specific geographical areas, such as the Ohio and Mississippi River valleys (Kern 1985).Infection is established after the inhalation of microconidia and hyphae.

After this, most people (approximately 90%) do not show any symptoms. Those that do become ill complain of mild, non-specific symptoms such as fever, chills, headache, chest pain, weight loss and arthritis. Fungal Pathogens in Humans Essay. Occasionally, the lung infection can become chronic, and the fungus forms small nodules in the lungs called histoplasmomas (Campbell and Stewart 1980). These nodules degrade the outer layers of the lung, and often resemble tuberculosis in appearance and symptomatology.Inflammation of the membranes covering the heart (pericarditis) and fibrosis of major blood vessels are also associated with this disease (Klein 2000).

Though there have been reported cases of spontaneous recovery of chronic pulmonary histoplasmosis, prognosis is rather grim-many chronic patients die within a few weeks to a few months (Ainsworth 1952). An interesting aspect of Histoplasma is that it lives a double life: one as a soil-dwelling mycelial saprobe and another as a pathogenic yeast living in mammalian tissues.This mycelial form is found in soil enriched with bird and bat droppings, and produces infections spores (Klein 2000). When the soil is disturbed, spores are inhaled into the respiratory tract, and the temperature change from twenty-five degrees Celsius to the mammalian body temperature of thirty-seven degrees Celsius stimulates the growth of the yeast form (Magrini and Goldman 2001). In an attempt to destroy the foreign yeast, the host’s macrophages and other cells of the reticulo-endothelial system engulf them (Klein 2000).

Unfortunately for the human, the yeasts survive and proliferate within the normally hostile environment of the phagolysosomes, cells formed by fusion of phagocytic vesicles with lysosomes (Sebghati and Goldman 2000). The yeast cells secrete enzymes that establish a more basic environment than usually present in the phagolysosomes, deactivating many lysosomal enzymes requiring a low pH (Klein 2000). Another way the host’s cells defend themselves is by withholding required nutrients such as iron and calcium from the intruders, sequestering them in the phagolysosomes (Weinberg 1999).In fact, there is a very low concentration of calcium in the very cells Histoplasma yeasts choose to call home.

The yeasts are able to grow in a calcium-deprived environment by secreting a 7. 8 kilodalton calcium binding protein (CBP). This knowledge has allowed researchers to isolate the CBP1 gene and they found that by disrupting it in fungal cultures, the yeasts lost their ability to survive in a calcium-limited environment. Interestingly, the saprophytic (mycelial) form of Histoplasma cannot survive without high levels of calcium in the environment, and does not secrete CBP (Magrini and Goldman 2001).The organism must have the CBP1 gene, but it is “turned off” in the mycelial form.

A probable reason for this missing protein is that the organism is conserving energy and resources, only producing CBP when conditions are guaranteed to be low in calcium. Thus, it is apparent that the evolution of the parasitic yeast form from the mycelial form was dependent on the incorporation of the CBP1 gene into the fungal genome. How CBP links the two phenotypes is at the moment unknown, but it remains that calcium acquisition is an important strategy for microbial survival in the intracellular compartments.Histoplasmosis is an example of an endemic disease, one that is able to produce an invasive infection in healthy individuals as the fungus is sufficiently virulent that it does not require help breaching the host’s immune system (Patterson and McGinnis 2003). Fungal Pathogens in Humans Essay. Another example of this type of systemic infection is Blastomycosis, caused by Blastomycetes dermatidis, also a thermally dimorphic ascomycete.

There are two forms of the disease: a cutaneous infection caused by direct contact with fungal spores through a cut, and a pulmonary infection from the inhalation of spores.Both of these infections may lead to a systemic disease, affecting a number of organs such as the brain and kidneys (Kern 1985). Another type of systemic fungal infection is opportunistic meaning the fungus is not able to harm individuals with healthy immune systems. AIDS and chemotherapy patients, as well as organ transplant recipients and others with lowered immune defences are at a high risk of developing this sort of uncommon invasive infection. For example, the mainly conidial Aspergillus causes a widely varied disease called Aspergillosis in immunocompromised individuals (Denning et al. 1991).

Aspergillus is a rather ubiquitous fungus, commonly isolated from soil, plant debris, and indoor air environments. Out of 185 recorded Aspergillus species, only 20 cause opportunistic infections in man, with Aspergillus fumigatus being the most commonly isolated species. Aspergillosis may at first present as a bronchopulmonary infection as Aspergillus colonizes in bronchial and lung tissue (Denning et al. 1991). The presence of Aspergillus in healthy individuals is not uncommon; in fact, many people have sustained microscopic pulmonary lesions identifiable only by biopsy, and have never suffered from any symptoms (Campbell and Stewart 1980).In immunocompromised individuals, however, the fungus tends to reside in larger lesions produced by prior infections such as tuberculosis or pneumonia and dissolves the already raw lung tissue.

This results in airway obstruction, coughing, and chest pain. The disease occasionally disseminates to other organs such as the heart, kidneys, and brain (Denning et al. 1991). While the initial infection is indeed caused by inhalation of spores, Aspergillus is not dimorphic like many other systemic disease-causing fungi. It grows in a mycelial form in the soil as well as in the human body (Patterson and McGinnis 2003).As with many other systemic diseases, Aspergillosis is most often fatal, and the host’s immune system is too badly damaged to repair the body.

Candidiasis Perhaps one of the best-known fungal is candidiasis, otherwise known as “thrush”, “monilla”, or a “yeast infection”. The spectrum diseases caused by the fungus Candida is quite extensive, ranging from simple colonization of mucosal membranes to multiple organ invasion (Sugar and Lyman 1997). Due to the large range of infections caused by members of Candida, it cannot be classified as strictly cutaneous, subcutaneous, or systemic.Though members from several species of the genus have been recovered in human infection, the most common medically important member is Candida albicans.

This organism is a normal inhabitant in the intestines and mucotaneous regions of healthy individuals. The fungal cells only become problematic when they congregate in one area, sparking an immune response from the host. Candidiasis is thus categorized as an endogenous disease (arising from the host), but also can be obtained exogenously from catheters, prosthetic devices, or through person-to-person contact.Generally, mild diseases such as oral candidiasis (thrush) or vaginitis occur in otherwise healthy individuals with a slight drop in immune system performance. In pregnant women, the likelihood of vaginal candidiasis is high since there is an increase in glycogen levels in mucosal tissues, which stimulates overgrowth of Candida. This infection may be passed as thrush to her baby following birth, before the natural flora of protective bacteria is established (Kendrick, 2000).

In the same way, adults taking antibiotics for a bacterial infection are quite susceptible to candidiases, since the lactobacilli that regularly keep this fungus in check are also destroyed along with the harmful bacteria (Kendrick 2000). Fungal Pathogens in Humans Essay.  Infections of the mucotaneous regions are usually identified by large white patches of yeast, white blood cells, debris, and bacteria. Candida albicans can adhere to host tissues using specialized proteins called adherins and produces aspartyl proteases and phospholipase enzymes, causing mild to severe swelling, itchiness and redness in the infected areas (Cole and Hoch 1991).Like opportunistic systemic diseases, Candida can also prey on those with weakened immune systems, causing chronic bronchial pulmonary or alimentary candidiasis.

These diseases are almost never seen in healthy people because the fungus is not strong enough to overcome a healthy immune system. The ability for yeasts to survive most of their lives in the human body arises from their ability to undergo morphological changes in certain conditions. Typically, C. albicans grows as single ellipsoidal cells called blastospores (blastoconidia).In the presence of inducing signals in the environment, the fungus can assume a filamentous form in which cells remain attached to each other after dividing, forming long branching strings of connecting cells (Hoffman 1992).

This filamentous form can assume the form of pseudohyphae in which cells are elongated but still ellipsoidal, or true hyphae where highly elongated cells forming the filament are cylindrical and separated by perpendicular septal walls (Braun and Johnson 1997). The morphological change is thought to contribute to colonization and dissemination within host tissues and promote infection.The main cause of filamentous growth in C. albicans is a shortage of food. Since these tiny cells cannot move, they grow toward a new food source by attaching to one another in a filament (Hoffman 1992). Fungal Pathogens in Humans Essay.

In the lab, high temperature, serum, high carbon dioxide to oxygen ratio, and neutral pH cause blastospores to sprout hyphae (Braun and Johnson 1997). One of the key genes responsible for filamentous growth is TUP1, first isolated from Saccaromyces cerevisiae, which until 1992, was not thought to have a filamentous form at all (Hoffman 1992).By isolating and disrupting TUP1, researchers have observed constitutive filamentous growth. This discovery leads to possible modes of treatment, perhaps by supplementing an infected individual with a compound that stimulates transcription of TUP1, in hopes to prevent filamentous growth (Braun and Johnson 1997). Treatment of Human Mycoses There are several drugs available to treat fungal infections in humans.

Until quite recently, however, diseases such as Histoplasmosis, Aspergillosis, and Blastomycosis were almost always fatal (Kendrick 2000).Nyastatin, produced in 1950, was one of the first successes in treatment of superficial and oesophageal candidiasis (Kendrick 2000). Amphotericin and Ketoconazole are useful in treating deep-seated systemic mycoses, but have several unpleasant side effects, and should only by administered as a last resort. Dermatophyte infections can also be treated using Canestin, Griseofluvin, Tolnaftate, and most recently, Terbinafine, with relatively mild side effects (McClellan et al. 1999).Some mycoses can also be prevented by diet and lifestyle changes.

For example, candidiasis can be prevented by keeping skin dry and wearing loose clothing, as fungal growth is encouraged by moist conditions. Also, several studies have shown that eating yoghurt every day will restore the natural flora of lactobacilli in the body, preventing yeast infections (Lewis 1992). Conclusions Despite the array of possible mycoses with which humans have been afflicted, severe systemic and subcutaneous diseases are still quite rare in North America. Fungal Pathogens in Humans Essay. Due to the increasing number of immunocompromised individuals, however, rare fungal diseases once found only in other animals are causing complications and death in these people.

The ability of kingdom Eumycota to thrive in both saprophytic and parasitic environments and change its morphology has contributed greatly to the success of fungi on Earth. As we continue to observe the evolution of saprophytic fungi to parasitic organisms, we must expect to see more mycoses affecting humans-we simply present an environment too ideal to pass up.

Fungal pathogens can be separated into two distinct groups; true or primary fungal pathogens, and opportunistic pathogens. True or primary pathogens can cause disease in any individual, regardless of their health status. Examples of these include Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis and Paracoccidioides brasiliensis, which cause disease in areas of endemicity. Opportunistic fungal pathogens are not sufficiently pathogenic to cause infection in healthy individuals, but are known to cause disease in individuals with a weak or depleted immune system. Examples of these opportunists include Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans, although in rare cases, Cryptococcus neoformans can cause infection in healthy individuals if a sufficient quantity is inhaled (Stein & Sugar 1989). True and opportunistic fungal pathogens can also be categorised as host acquired pathogenic fungi and environmental fungi, for example Candida albicans and Histoplasma capsulatum respectively (Casedevall and Pirofski 2006). Over 1.5 million fungal species are known to exist and of these only around 150 have been identified as causing disease in humans. Even so, only a handful of these are frequently encountered in a clinical setting, most of these being opportunistic infections (Casadevall & Pirofski 2006, D’Enfert 2009). These can infect humans superficially, sub-cutaneousmly or systemically, the latter becoming the most significant over the last couple of decades. Fungal Pathogens in Humans Essay.

These observations are due, at least in part, to factors such as the emergence and increase in incidence of other diseases and advances in medicine over the past couple of decades. The emergence of HIV/AIDS has increased the immunocompromised population dramatically, this is supported by the statistics from the World Health Organisation (WHO) that shows there are now 33 million people living with the disease and in 2007 it was estimated that approximately 2.7 million people were newly infected (www.who.int). The ability to perform solid organ transplants has given rise to an increase in immunosuppression due to the immunosuppressive drugs administered to the patient to prevent rejection of the transplanted organ by the patient’s immune system. Age now has an impact on the immune system, as due to medical advances the elderly are living longer and there is increasing survival of premature neonates (Pfaller & Diekema 2004). These and a variety of other factors have lead to an increase in the number of people who have become immunocompromised.

An important issue surrounding the opportunistic fungal pathogens is the emergence of opportunistic pathogenic fungi which have either never before been recognised or were thought to be non-pathogenic, for example Candida dubliniensis. These pathogenic fungi are becoming increasingly important due to the fact that individuals are becoming more and more immunosuppressed due to disease and medical advances discussed previously. This gives fungi, otherwise thought as being non-pathogenic; the opportunity to invade the host and cause disease that would not be possible in immunocompetant individuals. It is also seen that the more immunosuppressed the host, then the more susceptible they are to infection from more obscure fungi (Sanchez & Noskin 1998).

The ability of the fungal pathogen to cause disease in the human host depends on a range of factors including the state of the host immune system and any virulence factors that the micro-organism may possess. Fungal Pathogens in Humans Essay. The state of the immune system is a particularly important factor for the opportunistic fungal pathogens to establish disease. Other risk factors that may be associated with an increased risk of infection may differ depending on the organism, for example, airborne dust has been recognized as a risk factor in the development of Coccidiodomycosis (Warnock 2006). Virulence factors associated with all of the pathogenic fungi are, in most cases, not sufficient enough to cause a symptomatic disease, but in immunocompromised individuals dissemination can occur, which carry high mortality rates as they are difficult to treat effectively (Casadevall and Pirofski 2006).

Nosocomial infections are an area of interest as many emerging opportunistic fungal pathogens are presented in these environments along with the more common opportunists. This has become more significant due to the rise of immunocompromised patients in the hospital setting, and the use of artificial surfaces, for example, plastic intravenous lines, which breach the skin barrier. This is especially true for patients suffering from candidemia, where an intravenous line is the most frequent gateway into the host (Verduyn et al 1999).

It is now recognised Candida species are the third most frequent nosocomial bloodstream isolates’ (Perlroth et al 2007, Yoo et al 2009).

Due to the increasing immunocompromised population many of the emerging opportunistic fungal pathogens are seen to be resistant to certain antifungal therapies, for example azole resistance has been observed in Candida species (Yoo et al 2009). This problem is due to the fact that there is a limited spectrum of antifungal drugs available to treat these diseases. Also treatment is usually prolonged to fully eradicate the fungus and prevent relapse which along with a limited availability of antifungals can result in increased possibility of resistance. To prevent this other procedures such as surgery and reversal of immunosuppression are used in addition to the use of antifungals. There are also currently no available vaccines against any human fungal infection and therefore immunity to these diseases cannot be achieved via this route (Casadevall & Priofski 2006, Pfaller & Diekema 2004). Fungal Pathogens in Humans Essay.

Within this paper I aim to realize if the increase of immunodeficient individuals has been the main contribution to the increase in incidence of opportunistic infection and the emergence of new fungal pathogens or if other factors such as virulence factors and antifungal resistance play a more dominant part in the increase.

Histoplasma capsulatum is a dimorphic fungus that causes histoplasmosis in both immunocompetant and immunocompromised individuals (Kauffman 2007). H. capsulatum var. capsulatum is endemic in the USA, particularly in the Mississippi and Ohio River valleys, and Latin America (Wheat 2006). Soil rich in nitrogen is the natural habitat of the mould form of Histoplasma capsulatum, the source of nitrogen being the vast amounts of bird or bat guano which tend to be associated with the endemic areas (Kauffman 2007, Wheat 2006, CDC 2008, Anaissie et al 2009, Maresca et al 1994). Most cases of histoplasmosis are symptomless with the individual being unaware of the infection or mild cases which may be misdiagnosed. Only a small proportion of the patients with symptoms will go on to develop more serious conditions. These include chronic pulmonary histoplasmosis and disseminated histoplasmosis in immunocompromised individuals.

Of the many species of Candida, Candida albicansis the most common fungal pathogen of humans and is the most common cause of fungal infection in a hospital setting in the USA (Lunel et al 1999). C. albicans is a dimorphic fungus that is found, in its yeast form, as part of the normal flora of humans on mucosal surfaces in the genitourinary and gastrointestinal tract. This commensalism does not have an adverse effect on the host unless the host immune system is depressed or the normal flora is altered, for example, in the immunocompromised and individuals treated with antibiotics (D’Enfert 2009).

ORDER A PLAGIARISM-FREE PAPER NOW

References

CDC. Outbreak of Histoplasmosis among travellers returning from El Salvador—Pennsylvania and Virginia, 2008. MMWR (2008); 57(50): 1349-1353. Accessed 30th October 2009, from Accessed 10th November 2009

Ampel, NM (1996). Emerging Disease Issues and Fungal Pathogens Associated with HIV Infection. Emerging Infectious Disease. 2(2): 109-116

Anaissie, EJ, McGinnis, MR and Pfaller, MA (2009). Clinical microbiology, 2nd edition, Elsevier, China

Bernardis, FD, Sullivan, PA, Cassone, A (2001). Aspartyl proteinases of Candida albicans and their role in pathogenicity. Medical Mycology. 39: 303-313

Casadevall, A & Pirofski, L (2006). The weapon potential of human pathogenic fungi. Medical Mycology. 44: 689-696.

Chai, LYA, Netea, MG, Vonk, AG & Kullberg, B (2009). Fungal strategies for overcoming host innate immune response. Medical Mycology. 47: 227-236. Fungal Pathogens in Humans Essay.

D’Enfert, C (2009). Hidden killers: persistence of opportunistic fungal pathogens in the human host. Current opinion in microbiology, 12(4), 358-364.

Filler, SG & Sheppard, DC (2006). Fungal Invasion of Normally Non- Pathocytic Host Cells. PLoS Pathogens. 2(12): 1099-1105

Gantner, BN, Simmons, RM & Underhill, DM (2005). Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. The EMBO Journal. 24(6): 1227-1286

Grenouillet, F, Botterel, F, Crouzet, J, Larosa, F, Hicheri, Y, Forel, J, Helias, P, Ranque, S & Delhaes, L (2009). Scedosporium prolificans: an emerging pathogen in France? Medical mycology, 47 (special issue), 343-350.

Hogan, LH, Klein, BS, & Levitz, SM (1996). Virulence Factors of Medically Important Fungi. Clinical Microbiology Reviews. 9(4): 469-488

Kauffman, CA (2007). Histoplasmosis: a Clinical and Laboratory Update. Clinical Microbiology Reviews. 20(1): 115-132

Kurita, N, Terao, K, Brummer, E, Ito, E, Nishimura, K & Miyaji, M (1991). Resistance of Histoplasma capsulatum to killing by human neutrophils – Evasion of oxidative burst and lysosomal-fusion products. Mycopathologica. 115: 207-213.

Perlroth, J, Choi, B & Spellberg, B, (2007). Nosocomial fungal infections: epidemiology, diagnosis and treatment. Medical mycology, 45, 321-346.

Pfaller, MA and Diekema, DJ (2004). Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigates. Journal of clinical microbiology, 42 (10), 4419-4431.

Ponton, J, Ruchel, R, Clemons, KV, Coleman, DC, Grillots, R, Aldebert, D, Ambroise-Thomas, P, Cano, J, Carrillo-Munoz, AJ, Gene, J, Pinel, C, Stevens, DA & Sullivan, DJ (2000). Emerging pathogens. Medical mycology, 38 (supplement 1), 225-236.

Porta, A & Maresca, B (2000). Host response and Histoplasma capsulatum/macrophage molecular interactions. Medical Mycology. 38: 399-406.

Rappleye, CA, Eissenberg, LG & Goldman, WE (2007). Histoplasma capsulatum α-(1, 3)-glucan blocks innate immune recognition by the β-glucan receptor. Proceeding of the National Academy of Sciences. 104(4): 1366-1370

Romani, L, Bistoni, F & Puccetti, P (2002). Fungi, dendritic cells and receptors: a host perspective of fungal virulence. TRENDS in Microbiology. 10(11): 508-514

Sanchez, J & Noskin, GA, (1998). Management of Infectious Complications in Cancer Patients. Kluwer Academic Publishers. USA

Stein, DK & Sugar, AM (1989). Fungal Infections in the Immunocompromised Host. Diagnostic Microbiology and Infectious Disease. 12: 221S-228S

Tronchin, G, Pihet, M, Lopes-Bezerra, LM & Bouchara, JP (2008). Adherence mechanisms in human pathogenic fungi. Medical Mycology. 46: 749-772

Verduyn Lunel, FM, Meis, JFGM & Voss, A (1999). Nosocomial Fungal Infections: Candidemia. Diagnostic Microbiology and Infectious Disease. 34: 213-220

Vilela, MMS, Kamei, K, Sano, A, Tanaka, R, Uno, J, Takahashi, I, Ito, J, Yarita, K & Miyaji, M (2002). Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans. Medical Mycology. 40: 249-257. Fungal Pathogens in Humans Essay.

Walsh, TJ, Van Cutsem, J, Polak, AM & Graybill, JR (1992). Immunomodulation and antifungal therapy of experimental invasive candidosis, histoplasmosis and apergillosis: recent advances and concepts. Journal of Medical and Veterinary Mycology. 30; Supplement 1: 225-240

Warnock, DW (2006). Fungal diseases: an evolving public health challenge. Medical mycology, 44,697-705.

Wheat, JL (2006). Histoplasmosis: a review for clinicians from non-endemic areas. Mycoses. 49: 274-282.

Wheat, J (1994). Histoplasmosis: Recognition and Treatment. Clinical Infectious Diseases. 19(Supplement 1): S19-S27.

Woods, JP (2002). Histoplasma capsulatum Molecular Genetics, Pathogenesis, and Responsiveness to its Environment. Fungal Genetics and Biology. 35: 81-97

Yoo, JI, Choi, CW, Lee, KM, Kim, YK, Kim, TU, Kim, EC, Joo, SI, Yun, SH, Lee, YS, Kim, BS (2009). National surveillance of antifungal susceptibility of Candida species in South Korean hospitals. Medical Mycology. 47: 554-558.  Fungal Pathogens in Humans Essay.

start Whatsapp chat
Whatsapp for help
www.OnlineNursingExams.com
WE WRITE YOUR WORK AND ENSURE IT'S PLAGIARISM-FREE.
WE ALSO HANDLE EXAMS